Characterization and clinical course of patients not receiving aspirin for acute myocardial infarction: Results from the MITRA and MIR studies

American Heart Journal

Volumn 141, Issue 2, 2001, Pages 200-205

  Frilling, Birgit ^a   Schiele, Rudolf ^a   Gitt, Anselm Kai ^a   Zahn, Ralf ^a   Schneider, Steffen ^a   Glunz, Hans Georg ^b   Gieseler, Ulf ^c   Baumgärtel, Bernd ^d   Asbeck, Frank ^e   Senges, Jochen ^a  

^a Kardiologie   (Germany)

^b Westpfalzklinikum Kaiserslautern   (Germany)

^c Diakonissenkrankenhaus Speyer   (Germany)

^d Kreiskrankenhaus Freital   (Germany)

^e Stadtisches Krankenhaus Kiel   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DISEASE COURSE; DRUG CONTRAINDICATION; FEMALE; HEART INFARCTION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CODING; PRIORITY JOURNAL; STOMACH ULCER;

EID: 0035154554     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.112681     Document Type: Article

References (17)

1. Clinical features of sudden obstruction of the coronary orteries
2. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2
3. A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction
4. Aspirin Myocardial Infarction Research Group A randomized controlled trial of aspirin in persons recovered from myocardial infarction
5. A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction
6. Effects of early intervention with low-dose aspirin (100 mg) on infarct size, reinfarction and mortality in anterior wall acute myocardial infarction
7. Collaborative overview of randomized trials of anti-platelet therapy, I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients
8. Therapy of acute myocardial infarction, impact of clinical trials an clinical practice: The MITRA pilot phase
9. Acute myocardial infarction between 1996 and 1998: Therapy and intrahospital course. Results of the myocardial infarction registry (MIR) in Germany
10. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction
11. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: The MILIS-TIMI experience
12. Treatment of myocardial infarction in the United States (1990 to 1993): Observations from the National Registry of Myocardial Infarction
13. MITRA: Maximal individual therapy in acute myocardial infarction is associated with a lower hospital mortality
14. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction
15. Sex-based differences in early mortality after myocardial infarction
16. Causes of higher in-hospital mortality in women than in men after acute myocardial infarction
17. Gender differences in the treatment of patients with acute myocardial infarction: A multihospital, community-based perspective